Showing results (1641-1650 of 1,670) with videos related to
Sort By:
Pageof 167
Blood|August 24, 2013
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemiasChristopher J Walker, Joshua J Oaks, Ramasamy Santhanam, et al.Biorxiv : the Preprint Server for Biology|December 3, 2025
Shared neural geometries for bilingual semantic representationsXinyuan Yan, Aaditya Krishna, Katie Van Arsdel, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2017
Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's diseaseNaomi P Visanji, Grace S Bhudhikanok, Tiago A Mestre, et al.Blood|March 6, 2002
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 studyMoshe Talpaz, Richard T Silver, Brian J Druker, et al.Blood|September 9, 2006
Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disordersMarianna David, Nicholas C P Cross, Sonja Burgstaller, et al.The Oncologist|August 3, 2021
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint InhibitorsDylan J Martini, Julie M Shabto, Subir Goyal, et al.Blood|August 9, 2013
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignanciesJoshua J Oaks, Ramasamy Santhanam, Christopher J Walker, et al.Innovations (Philadelphia, Pa.)|September 24, 2016
Minimally Invasive Mitral Valve Surgery III: Training and Robotic-Assisted ApproachesEric J Lehr, T Sloane Guy, Robert L Smith, et al.Leukemia|January 1, 1996
Chemotherapy versus transplants for acute myelogenous leukemia in second remissionR P Gale, M M Horowitz, J K Rees, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblingsR Szydlo, J M Goldman, J P Klein, et al.Pageof 167